Global Specialty Generics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Specialty Generics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.5% in the forecast period of 2020 to 2025 and will expected to reach USD 53430 million by 2025, from USD 41600 million in 2019.
The Specialty Generics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Specialty Generics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Specialty Generics market has been segmented into:
Injectables
Oral
Others
By Application, Specialty Generics has been segmented into:
Oncology
Inflammatory Conditions
Multiple Sclerosis
Hepatitis C
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Specialty Generics market presented in the report. This section sheds light on the sales growth of different regional and country-level Specialty Generics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Specialty Generics market.
The report offers in-depth assessment of the growth and other aspects of the Specialty Generics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Specialty Generics Market Share Analysis
Specialty Generics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Specialty Generics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Specialty Generics sales, revenue and market share for each player covered in this report.
The major players covered in Specialty Generics are:
Teva Pharmaceuticals USA, Inc.
Endo Pharmaceuticals Inc.
Akorn, Inc.
Mylan N.V.
Pfizer Inc.
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International, Inc.
Mallinckrodt
Apotex Corp.
Table of Contents
1 Specialty Generics Market Overview
1.1 Product Overview and Scope of Specialty Generics
1.2 Classification of Specialty Generics by Type
1.2.1 Global Specialty Generics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Specialty Generics Revenue Market Share by Type in 2019
1.2.3 Injectables
1.2.4 Oral
1.2.5 Others
1.3 Global Specialty Generics Market by Application
1.3.1 Overview: Global Specialty Generics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Inflammatory Conditions
1.3.4 Multiple Sclerosis
1.3.5 Hepatitis C
1.4 Global Specialty Generics Market by Regions
1.4.1 Global Specialty Generics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Specialty Generics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Specialty Generics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Specialty Generics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Specialty Generics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Specialty Generics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Specialty Generics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Teva Pharmaceuticals USA, Inc.
2.1.1 Teva Pharmaceuticals USA, Inc. Details
2.1.2 Teva Pharmaceuticals USA, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceuticals USA, Inc. SWOT Analysis
2.1.4 Teva Pharmaceuticals USA, Inc. Product and Services
2.1.5 Teva Pharmaceuticals USA, Inc. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Endo Pharmaceuticals Inc.
2.2.1 Endo Pharmaceuticals Inc. Details
2.2.2 Endo Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Endo Pharmaceuticals Inc. SWOT Analysis
2.2.4 Endo Pharmaceuticals Inc. Product and Services
2.2.5 Endo Pharmaceuticals Inc. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Akorn, Inc.
2.3.1 Akorn, Inc. Details
2.3.2 Akorn, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Akorn, Inc. SWOT Analysis
2.3.4 Akorn, Inc. Product and Services
2.3.5 Akorn, Inc. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mylan N.V.
2.4.1 Mylan N.V. Details
2.4.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mylan N.V. SWOT Analysis
2.4.4 Mylan N.V. Product and Services
2.4.5 Mylan N.V. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer Inc. SWOT Analysis
2.5.4 Pfizer Inc. Product and Services
2.5.5 Pfizer Inc. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sandoz International GmbH
2.6.1 Sandoz International GmbH Details
2.6.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sandoz International GmbH SWOT Analysis
2.6.4 Sandoz International GmbH Product and Services
2.6.5 Sandoz International GmbH Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharmaceutical Industries Ltd.
2.7.1 Sun Pharmaceutical Industries Ltd. Details
2.7.2 Sun Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sun Pharmaceutical Industries Ltd. SWOT Analysis
2.7.4 Sun Pharmaceutical Industries Ltd. Product and Services
2.7.5 Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Valeant Pharmaceuticals International, Inc.
2.8.1 Valeant Pharmaceuticals International, Inc. Details
2.8.2 Valeant Pharmaceuticals International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Valeant Pharmaceuticals International, Inc. SWOT Analysis
2.8.4 Valeant Pharmaceuticals International, Inc. Product and Services
2.8.5 Valeant Pharmaceuticals International, Inc. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mallinckrodt
2.9.1 Mallinckrodt Details
2.9.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mallinckrodt SWOT Analysis
2.9.4 Mallinckrodt Product and Services
2.9.5 Mallinckrodt Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Apotex Corp.
2.10.1 Apotex Corp. Details
2.10.2 Apotex Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Apotex Corp. SWOT Analysis
2.10.4 Apotex Corp. Product and Services
2.10.5 Apotex Corp. Specialty Generics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Specialty Generics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Specialty Generics Players Market Share
3.2.2 Top 10 Specialty Generics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Specialty Generics Revenue and Market Share by Regions
4.2 North America Specialty Generics Revenue and Growth Rate (2015-2020)
4.3 Europe Specialty Generics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Specialty Generics Revenue and Growth Rate (2015-2020)
4.5 South America Specialty Generics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Specialty Generics Revenue and Growth Rate (2015-2020)
5 North America Specialty Generics Revenue by Countries
5.1 North America Specialty Generics Revenue by Countries (2015-2020)
5.2 USA Specialty Generics Revenue and Growth Rate (2015-2020)
5.3 Canada Specialty Generics Revenue and Growth Rate (2015-2020)
5.4 Mexico Specialty Generics Revenue and Growth Rate (2015-2020)
6 Europe Specialty Generics Revenue by Countries
6.1 Europe Specialty Generics Revenue by Countries (2015-2020)
6.2 Germany Specialty Generics Revenue and Growth Rate (2015-2020)
6.3 UK Specialty Generics Revenue and Growth Rate (2015-2020)
6.4 France Specialty Generics Revenue and Growth Rate (2015-2020)
6.5 Russia Specialty Generics Revenue and Growth Rate (2015-2020)
6.6 Italy Specialty Generics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Specialty Generics Revenue by Countries
7.1 Asia-Pacific Specialty Generics Revenue by Countries (2015-2020)
7.2 China Specialty Generics Revenue and Growth Rate (2015-2020)
7.3 Japan Specialty Generics Revenue and Growth Rate (2015-2020)
7.4 Korea Specialty Generics Revenue and Growth Rate (2015-2020)
7.5 India Specialty Generics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Specialty Generics Revenue and Growth Rate (2015-2020)
8 South America Specialty Generics Revenue by Countries
8.1 South America Specialty Generics Revenue by Countries (2015-2020)
8.2 Brazil Specialty Generics Revenue and Growth Rate (2015-2020)
8.3 Argentina Specialty Generics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Specialty Generics by Countries
9.1 Middle East & Africa Specialty Generics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Specialty Generics Revenue and Growth Rate (2015-2020)
9.3 UAE Specialty Generics Revenue and Growth Rate (2015-2020)
9.4 Egypt Specialty Generics Revenue and Growth Rate (2015-2020)
9.5 South Africa Specialty Generics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Specialty Generics Revenue and Market Share by Type (2015-2020)
10.2 Global Specialty Generics Market Forecast by Type (2019-2024)
10.3 Injectables Revenue Growth Rate (2015-2025)
10.4 Oral Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Specialty Generics Market Segment by Application
11.1 Global Specialty Generics Revenue Market Share by Application (2015-2020)
11.2 Specialty Generics Market Forecast by Application (2019-2024)
11.3 Oncology Revenue Growth (2015-2020)
11.4 Inflammatory Conditions Revenue Growth (2015-2020)
11.5 Multiple Sclerosis Revenue Growth (2015-2020)
11.6 Hepatitis C Revenue Growth (2015-2020)
12 Global Specialty Generics Market Size Forecast (2021-2025)
12.1 Global Specialty Generics Market Size Forecast (2021-2025)
12.2 Global Specialty Generics Market Forecast by Regions (2021-2025)
12.3 North America Specialty Generics Revenue Market Forecast (2021-2025)
12.4 Europe Specialty Generics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Specialty Generics Revenue Market Forecast (2021-2025)
12.6 South America Specialty Generics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Specialty Generics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Specialty Generics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Specialty Generics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Specialty Generics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Specialty Generics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Teva Pharmaceuticals USA, Inc. Corporate Information, Location and Competitors
Table 6. Teva Pharmaceuticals USA, Inc. Specialty Generics Major Business
Table 7. Teva Pharmaceuticals USA, Inc. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 8. Teva Pharmaceuticals USA, Inc. SWOT Analysis
Table 9. Teva Pharmaceuticals USA, Inc. Specialty Generics Product and Solutions
Table 10. Teva Pharmaceuticals USA, Inc. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Endo Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 12. Endo Pharmaceuticals Inc. Specialty Generics Major Business
Table 13. Endo Pharmaceuticals Inc. Specialty Generics Total Revenue (USD Million) (2018-2019)
Table 14. Endo Pharmaceuticals Inc. SWOT Analysis
Table 15. Endo Pharmaceuticals Inc. Specialty Generics Product and Solutions
Table 16. Endo Pharmaceuticals Inc. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Akorn, Inc. Corporate Information, Location and Competitors
Table 18. Akorn, Inc. Specialty Generics Major Business
Table 19. Akorn, Inc. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 20. Akorn, Inc. SWOT Analysis
Table 21. Akorn, Inc. Specialty Generics Product and Solutions
Table 22. Akorn, Inc. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mylan N.V. Corporate Information, Location and Competitors
Table 24. Mylan N.V. Specialty Generics Major Business
Table 25. Mylan N.V. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 26. Mylan N.V. SWOT Analysis
Table 27. Mylan N.V. Specialty Generics Product and Solutions
Table 28. Mylan N.V. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Inc. Corporate Information, Location and Competitors
Table 30. Pfizer Inc. Specialty Generics Major Business
Table 31. Pfizer Inc. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer Inc. SWOT Analysis
Table 33. Pfizer Inc. Specialty Generics Product and Solutions
Table 34. Pfizer Inc. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sandoz International GmbH Corporate Information, Location and Competitors
Table 36. Sandoz International GmbH Specialty Generics Major Business
Table 37. Sandoz International GmbH Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 38. Sandoz International GmbH SWOT Analysis
Table 39. Sandoz International GmbH Specialty Generics Product and Solutions
Table 40. Sandoz International GmbH Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sun Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 42. Sun Pharmaceutical Industries Ltd. Specialty Generics Major Business
Table 43. Sun Pharmaceutical Industries Ltd. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 44. Sun Pharmaceutical Industries Ltd. SWOT Analysis
Table 45. Sun Pharmaceutical Industries Ltd. Specialty Generics Product and Solutions
Table 46. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Valeant Pharmaceuticals International, Inc. Corporate Information, Location and Competitors
Table 48. Valeant Pharmaceuticals International, Inc. Specialty Generics Major Business
Table 49. Valeant Pharmaceuticals International, Inc. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 50. Valeant Pharmaceuticals International, Inc. SWOT Analysis
Table 51. Valeant Pharmaceuticals International, Inc. Specialty Generics Product and Solutions
Table 52. Valeant Pharmaceuticals International, Inc. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Mallinckrodt Corporate Information, Location and Competitors
Table 54. Mallinckrodt Specialty Generics Major Business
Table 55. Mallinckrodt Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 56. Mallinckrodt SWOT Analysis
Table 57. Mallinckrodt Specialty Generics Product and Solutions
Table 58. Mallinckrodt Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Apotex Corp. Corporate Information, Location and Competitors
Table 60. Apotex Corp. Specialty Generics Major Business
Table 61. Apotex Corp. Specialty Generics Total Revenue (USD Million) (2017-2018)
Table 62. Apotex Corp. SWOT Analysis
Table 63. Apotex Corp. Specialty Generics Product and Solutions
Table 64. Apotex Corp. Specialty Generics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Specialty Generics Revenue (Million USD) by Players (2015-2020)
Table 66. Global Specialty Generics Revenue Share by Players (2015-2020)
Table 67. Global Specialty Generics Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Specialty Generics Revenue Market Share by Regions (2015-2020)
Table 69. North America Specialty Generics Revenue by Countries (2015-2020)
Table 70. North America Specialty Generics Revenue Market Share by Countries (2015-2020)
Table 71. Europe Specialty Generics Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Specialty Generics Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Specialty Generics Revenue by Countries (2015-2020)
Table 74. South America Specialty Generics Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Specialty Generics Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Specialty Generics Revenue Market Share by Countries (2015-2020)
Table 77. Global Specialty Generics Revenue (Million USD) by Type (2015-2020)
Table 78. Global Specialty Generics Revenue Share by Type (2015-2020)
Table 79. Global Specialty Generics Revenue Forecast by Type (2021-2025)
Table 80. Global Specialty Generics Revenue by Application (2015-2020)
Table 81. Global Specialty Generics Revenue Share by Application (2015-2020)
Table 82. Global Specialty Generics Revenue Forecast by Application (2021-2025)
Table 83. Global Specialty Generics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Specialty Generics Picture
Figure 2. Global Specialty Generics Revenue Market Share by Type in 2019
Figure 3. Injectables Picture
Figure 4. Oral Picture
Figure 5. Others Picture
Figure 6. Specialty Generics Revenue Market Share by Application in 2019
Figure 7. Oncology Picture
Figure 8. Inflammatory Conditions Picture
Figure 9. Multiple Sclerosis Picture
Figure 10. Hepatitis C Picture
Figure 11. Global Specialty Generics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Specialty Generics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Specialty Generics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Specialty Generics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Specialty Generics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Specialty Generics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Specialty Generics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Specialty Generics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Specialty Generics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Specialty Generics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Specialty Generics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Specialty Generics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Specialty Generics Revenue Market Share by Regions in 2018
Figure 25. North America Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 28. South America Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 30. North America Specialty Generics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Specialty Generics Revenue Market Share by Countries in 2019
Figure 32. USA Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Specialty Generics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Specialty Generics Revenue Market Share by Countries in 2019
Figure 37. Germany Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 38. UK Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 39. France Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Specialty Generics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Specialty Generics Revenue Market Share by Countries in 2019
Figure 44. China Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 47. India Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 49. South America Specialty Generics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Specialty Generics Revenue Market Share by Countries in 2019
Figure 51. Brazil Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Specialty Generics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Specialty Generics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Specialty Generics Revenue and Growth Rate (2015-2020)
Figure 59. Global Specialty Generics Revenue Share by Type (2015-2020)
Figure 60. Global Specialty Generics Revenue Share by Type in 2019
Figure 61. Global Specialty Generics Market Share Forecast by Type (2021-2025)
Figure 62. Global Injectables Revenue Growth Rate (2015-2020)
Figure 63. Global Oral Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global Specialty Generics Revenue Share by Application (2015-2020)
Figure 66. Global Specialty Generics Revenue Share by Application in 2019
Figure 67. Global Specialty Generics Market Share Forecast by Application (2021-2025)
Figure 68. Global Oncology Revenue Growth Rate (2015-2020)
Figure 69. Global Inflammatory Conditions Revenue Growth Rate (2015-2020)
Figure 70. Global Multiple Sclerosis Revenue Growth Rate (2015-2020)
Figure 71. Global Hepatitis C Revenue Growth Rate (2015-2020)
Figure 72. Global Specialty Generics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Specialty Generics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Specialty Generics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Specialty Generics Revenue Market Forecast (2021-2025)
Figure 76. Europe Specialty Generics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Specialty Generics Revenue Market Forecast (2021-2025)
Figure 78. South America Specialty Generics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Specialty Generics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Teva Pharmaceuticals USA, Inc.
Endo Pharmaceuticals Inc.
Akorn, Inc.
Mylan N.V.
Pfizer Inc.
Sandoz International GmbH
Sun Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International, Inc.
Mallinckrodt
Apotex Corp.
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets